CARDIAC MANAGEMENT AND LONG-TERM FOLLOW-UP OF BREAST CANCER PATIENTS WHO DEVELOP MILD LEFT VENTRICULAR DYSFUNCTION WHILE ON TRASTUZUMAB THERAPY

2017 ◽  
Vol 33 (10) ◽  
pp. S74
Author(s):  
R. Yao ◽  
J. Gibson ◽  
C. Simmons ◽  
M. Davis
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Breast Cancer Patients ◽  
Trastuzumab Therapy ◽  
Long Term Follow Up

Cardiac safety of continuous trastuzumab therapy in breast cancer patients with asymptomatic left ventricular dysfunction.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e11602-e11602
Author(s):  
Anthony Francis Yu ◽  
Nandini U Yadav ◽  
Anne Eaton ◽  
Betty Y Lung ◽  
Howard T. Thaler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Breast Cancer Patients ◽  
Cardiac Safety ◽  
Trastuzumab Therapy

scholarly journals Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction

2015 ◽  
Vol 20 (10) ◽  
pp. 1105-1110 ◽  
Author(s):  
Anthony F. Yu ◽  
Nandini U. Yadav ◽  
Anne A. Eaton ◽  
Betty Y. Lung ◽  
Howard T. Thaler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Breast Cancer Patients ◽  
Trastuzumab Therapy

Is Breast Cancer Ever Cured? Follow-Up Study of 5623 Breast Cancer Patients

1991 ◽  
Vol 77 (6) ◽  
pp. 465-467 ◽  
Author(s):  
Stefano Ciatto ◽  
Rita Bonardi
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Systemic Disease ◽  
Cancer Death ◽  
Breast Cancer Patients ◽  
Death Rates ◽  
Breast Cancer Death ◽  
Long Term Follow Up

The authors evaluated 5623 cases of primary breast cancer followed for 1 to 21 years. Overall and breast cancer death rates were determined and compared to expected rates. Breast cancer patients showed overall and breast cancer death rates significantly higher than expected and which persisted at long-term follow-up. The observed/expected overall death ratios for follow-up periods of 0–5, 6–10, 11–15 or 16–20 years were 3.61, 2.55, 1.60 and 2.11, respectively. Death rates from breast cancer at 5, 10, 15 and 20 years were 20%, 32%, 40% and 48% respectively. The evidence of a persistent excess mortality even after long-term follow-up suggests the hypothesis that breast cancer is a systemic disease when clinically diagnosed. This study provided no evidence of a « clinical » cure for breast cancer patients. Even for N- patients the 5, 10, 15 and 20 year death rates from breast cancer were 12%, 20%, 28% and 38%, respectively. N- breast cancer, which is currently considered as a localized disease cured by surgery in most cases, would be better regarded to as a slow-growing metastatic disease, although « personal » cure may be achieved in many subjects dying of causes other than breast cancer.

Brachial Plexopathy After Postoperative Radiotherapy of Breast Cancer Patients: A Long-Term Follow-up

2000 ◽  
Vol 39 (3) ◽  
pp. 373-382 ◽  
Author(s):  
Silvia Johansson ◽  
Hans Svensson ◽  
Lars-Gunnar Larsson ◽  
Juliana Denekamp
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Postoperative Radiotherapy ◽  
Brachial Plexopathy ◽  
Breast Cancer Patients ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document